ArticleInternational journal of molecular sciences2020

Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer.

Leonard Leong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.